ACE-031, at a strength of 1mg, is now generating significant interest across the European continent. Early clinical assessments in nations such as Germany, the French Republic, and the United Kingdom have revealed positive results in treating certain nervous system conditions. Regulatory agencies across the region are carefully reviewing the dat… Read More